Association of Long-Term Tacrolimus (FK506) Therapy with Abnormal Megakaryocytosis, Bone Marrow Fibrosis, and Dyserythropoiesis
Clinical case reports(2015)
Abstract
Haematopoietic abnormalities associated with tacrolimus are relatively rare with reversible pure red cell aplasia being the most common. We report for the first time, to our best knowledge, tacrolimus therapy associated with bone marrow fibrosis, abnormal megakaryocytosis, and dyserythopoiesis in a 17-year-old male treated with tacrolimus for nephrotic syndrome.
MoreTranslated text
Key words
Dyserythropoiesis,fibrosis,megakaryocytois,tacrolimus
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined